Comparison of glatiramer acetate (Copaxone) and interferon beta-1b (Betaferon) in multiple sclerosis patients: an open-label 2-year follow-up.

@article{Flechter2002ComparisonOG,
  title={Comparison of glatiramer acetate (Copaxone) and interferon beta-1b (Betaferon) in multiple sclerosis patients: an open-label 2-year follow-up.},
  author={Shlomo Flechter and Jacob Vardi and L Pollak and Jos{\'e} Martin Rabey},
  journal={Journal of the neurological sciences},
  year={2002},
  volume={197 1-2},
  pages={51-5}
}
OBJECTIVE To compare the clinical efficacy, as expressed by relapse rate and disability accumulation, and safety profile of glatiramer acetate (Copaxone; COP-1) and Interferon beta-1b (Betaferon; IFN beta - 1b) administered to multiple sclerosis patients during a 2-year follow-up on an open-label parallel design, as compared to their clinical condition in the 2-year period prior to treatment. BACKGROUND Copaxone and IFN beta - 1b have been recently introduced for the treatment of relapsing… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 14 extracted citations

Similar Papers

Loading similar papers…